WYNN BOYLE: Open Payments
NPI 1235298654 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 15 payments from 11 companies in 2025. Trend: 2023 $431 · 2024 $459 · 2025 $300
Food & beverage: $300
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 2 | $47 |
| Amphastar Pharmaceuticals, Inc. | 2 | $45 |
| Esperion Therapeutics, Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $39 |
| PFIZER INC. | 1 | $29 |
| Dexcom, Inc. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| BETA BIONICS, INC. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $16 |
Products named: The Cologuard Plus Collection Kit, NEXLETOL, MOUNJARO, PREVNAR 20, Dexcom G6 Transmitter, JARDIANCE, iLet Bionic Pancreas, GVOKE HYPOPEN.
Industry payments across MD — which companies pay providers there.
